ALITRETINOIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 6 adverse event reports in the FDA FAERS database where ALITRETINOIN was used for Psoriasis.
Most Reported Side Effects for ALITRETINOIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 20 | 25.0% | 0 | 0 |
| Breast cancer | 14 | 17.5% | 0 | 0 |
| Drug intolerance | 12 | 15.0% | 0 | 0 |
| Off label use | 12 | 15.0% | 0 | 1 |
| Pruritus | 12 | 15.0% | 0 | 0 |
| Hepatic enzyme increased | 11 | 13.8% | 0 | 0 |
| Blister | 9 | 11.3% | 0 | 0 |
| Pain in extremity | 9 | 11.3% | 0 | 0 |
| Psoriatic arthropathy | 9 | 11.3% | 0 | 0 |
| Skin injury | 9 | 11.3% | 0 | 0 |
| Abdominal discomfort | 8 | 10.0% | 0 | 0 |
| Treatment failure | 8 | 10.0% | 0 | 0 |
| C-reactive protein increased | 7 | 8.8% | 0 | 0 |
| Hypercholesterolaemia | 7 | 8.8% | 0 | 1 |
| Xerophthalmia | 7 | 8.8% | 0 | 0 |
Other Indications for ALITRETINOIN
Product used for unknown indication (20)
Pityriasis rubra pilaris (14)
Neurodermatitis (11)
Pustular psoriasis (9)
Kaposi's sarcoma (5)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)